Despite strong bipartisan support for a repeal of the onerous excise tax on health benefits, its fate in the Senate remains unclear.
Mercer offers a comprehensive look at what health plan sponsors should be thinking about this contract season.
The long-entrenched system of drug-manufacturer rebates has not adapted to changes in health-plan designs and labor-market trends.
With the tax perhaps unlikely to ever take effect, should companies still factor it into their benefits planning and strategies?
The government's deceit regarding the tax on rich health plans, and a possible delay in its effective date, aren't doing plan sponsors any favors.
However, employers' disdain for several aspects of the law, and their wish for changes to it, remain intact.
While millions would become uninsured if the bill became law, group health plans would mostly benefit, observers say.
Republicans may not be able to quickly dismantle President Obama's signature health-care law.
If the Affordable Care Act is fully repealed, employers will surely benefit, says an attorney who helped create it nine years ago.
Save the good and revise the bad, says Brian Marcotte of the National Business Group on Health
Following this week's elections, CFOs are again in the dark about the outlook for the cost, delivery, and quality of company-sponsored health care.
Companies race against the clock and employ new strategies in their bid to avoid an onerous excise tax that takes effect in four years.
